![Synthesis and Pharmacological Characterization of a Difluorinated Analogue of Reduced Haloperidol as a Sigma-1 Receptor Ligand | ACS Chemical Neuroscience Synthesis and Pharmacological Characterization of a Difluorinated Analogue of Reduced Haloperidol as a Sigma-1 Receptor Ligand | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.2c00791/asset/images/medium/cn2c00791_0002.gif)
Synthesis and Pharmacological Characterization of a Difluorinated Analogue of Reduced Haloperidol as a Sigma-1 Receptor Ligand | ACS Chemical Neuroscience
![PDF) Effect of haloperidol on behavioral sensitization and cognition in methylphenidate and buspirone-methylphenidate co-administered rats PDF) Effect of haloperidol on behavioral sensitization and cognition in methylphenidate and buspirone-methylphenidate co-administered rats](https://i1.rgstatic.net/publication/327371441_Effect_of_haloperidol_on_behavioral_sensitization_and_cognition_in_methylphenidate_and_buspirone-methylphenidate_co-administered_rats/links/5ba28585a6fdccd3cb630d32/largepreview.png)
PDF) Effect of haloperidol on behavioral sensitization and cognition in methylphenidate and buspirone-methylphenidate co-administered rats
Synthesis and Pharmacological Characterization of a Difluorinated Analogue of Reduced Haloperidol as a Sigma-1 Receptor Ligand | ACS Chemical Neuroscience
![Biomedicines | Free Full-Text | Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis Biomedicines | Free Full-Text | Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis](https://pub.mdpi-res.com/biomedicines/biomedicines-10-02972/article_deploy/html/images/biomedicines-10-02972-ag.png?1668774671)
Biomedicines | Free Full-Text | Antipsychotic Abuse, Dependence, and Withdrawal in the Pediatric Population: A Real-World Disproportionality Analysis
Effect of haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE randomised controlled trial, 2019
![The HaVOC Trial: IV Haloperidol vs Ondansetron for Cannabis Hyperemesis Syndrome - REBEL EM - Emergency Medicine Blog The HaVOC Trial: IV Haloperidol vs Ondansetron for Cannabis Hyperemesis Syndrome - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2020/12/Haloperidol-Evidence-copy-1024x497.jpg)
The HaVOC Trial: IV Haloperidol vs Ondansetron for Cannabis Hyperemesis Syndrome - REBEL EM - Emergency Medicine Blog
![PDF) Prior Haloperidol, but not Olanzapine, Exposure Augments the Pursuit of Reward Cues: Implications for Substance Abuse in Schizophrenia PDF) Prior Haloperidol, but not Olanzapine, Exposure Augments the Pursuit of Reward Cues: Implications for Substance Abuse in Schizophrenia](https://i1.rgstatic.net/publication/230749216_Prior_Haloperidol_but_not_Olanzapine_Exposure_Augments_the_Pursuit_of_Reward_Cues_Implications_for_Substance_Abuse_in_Schizophrenia/links/5512d4f70cf20bfdad521f8e/largepreview.png)
PDF) Prior Haloperidol, but not Olanzapine, Exposure Augments the Pursuit of Reward Cues: Implications for Substance Abuse in Schizophrenia
![Haloperidol prophylaxis in critically ill patients with a high risk for delirium | Critical Care | Full Text Haloperidol prophylaxis in critically ill patients with a high risk for delirium | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fcc11933/MediaObjects/13054_2012_Article_1049_Fig1_HTML.jpg)
Haloperidol prophylaxis in critically ill patients with a high risk for delirium | Critical Care | Full Text
![PDF) Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial PDF) Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial](https://i1.rgstatic.net/publication/323331259_Olanzapine_and_haloperidol_for_the_treatment_of_acute_symptoms_of_mental_disorders_induced_by_amphetamine-type_stimulants_A_randomized_controlled_trial/links/5aa9bfc20f7e9b88266f6558/largepreview.png)
PDF) Olanzapine and haloperidol for the treatment of acute symptoms of mental disorders induced by amphetamine-type stimulants: A randomized controlled trial
![The HaVOC Trial: IV Haloperidol vs Ondansetron for Cannabis Hyperemesis Syndrome - REBEL EM - Emergency Medicine Blog The HaVOC Trial: IV Haloperidol vs Ondansetron for Cannabis Hyperemesis Syndrome - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2020/12/HaVOC-Trial.png)
The HaVOC Trial: IV Haloperidol vs Ondansetron for Cannabis Hyperemesis Syndrome - REBEL EM - Emergency Medicine Blog
![Haloperidol Regulates the State of Phosphorylation of Ribosomal Protein S6 via Activation of PKA and Phosphorylation of DARPP-32 | Neuropsychopharmacology Haloperidol Regulates the State of Phosphorylation of Ribosomal Protein S6 via Activation of PKA and Phosphorylation of DARPP-32 | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnpp.2011.144/MediaObjects/41386_2011_Article_BFnpp2011144_Fig1_HTML.jpg)